Clinical Trial Update: A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating Modakafusp alfa in adults with multiple myeloma has been terminated, and trial results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Modakafusp Alfa (modakafusp alfa)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D LLC | Conditions: Multiple Myeloma | Phase 1 | Status: TERMINATED | Results posted: 2025-08-06